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To develop novel tumor cell microenvironment stimuli-responsive smart controlled-
release delivery systems is one of the current common interests of materials science and
clinical medicine. Meanwhile, mesoporous silica nanoparticles as a promising drug carrier
have become the new area of interest in the field of biomedical application in recent years
because of their unique characteristics and abilities to efficiently and specifically entrap
cargo molecules. This review describes the more recent developments and achievements
of mesoporous silica nanoparticles in drug delivery. In particular, we focus on the stimuli-
responsive controlled-release systems that are able to respond to tumor cell environmental
changes, such as pH, glucose, adenosine-50-triphosphate (ATP), glutathione (GSH), and
H2O2.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
The development of stimuli-responsive nanomaterials for
cancer treatment has been receiving extensive attention in
recent years and now has become a principal field in medical
research [1e4]. In cancer therapy, to achieve the complete
eradication of tumors, anticancer drugsmust be administered
systematically in high doses to ensure sufficient and sus-
tained therapy. However, sustained drug delivery systemswill
cause severe side-effects because of the nonspecific uptake of
anticancer drugs by healthy tissues/organs such as liver,istry, Fuzhou University
hu).
inistration, Taiwan. Publikidney, bone marrow, and heart before reaching the targeted
organs or tissues [5]. Therefore, it is highly desirable to design
stimuli-responsive controlled drug delivery systems (CDDSs).
In this system, the vehicles loadedwith drugmolecules can be
capped by various “gatekeepers.” Being blocked, drug mole-
cules are unable to be leached out from the host, thus pre-
venting any premature release. The release is triggered only
upon exposure to stimuli, which induce the removal of gate-
keepers and then the release of the entrapped drugmolecules.
Among the various dedicated materials for drug delivery ap-
plications, multifunctional mesoporous silica nanoparticles
(MSNs) are particularly interesting candidates for powerful, Fuzhou 350108, PR China.
shed by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license. 
Fig. 1 e A graphical representation of the pH responsive MSN nanovalve. (A) Synthesis of the stalk, loading of the cargo,
capping of the pore, and release of the cap under acidic conditions. Based on previous calculations, themaximumnumber of
stalks per nanopore is six and the maximum number of fully assembled nanovalves per nanopore is four. The average
nanopore diameter of the MSN is around 2.2 nm, and the periphery diameter of the secondary side of b-cyclodextrin is
about 1.5 nm. Thus, for a cargo with a diameter 40.7 nm, a single nanovalve should be adequate to achieve effective pH-
modulated release. (B) Details of the protonation of the stalk and release of the b-cyclodextrin. (C) TEM image of cappedMSN.
The scale bar is 100 nm. MSN [ mesoporous silica nanoparticle; TEM [ transmission electron microscopy. Note. From
“Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves,” by H.
Meng, M. Xue, T. Xia, et al, 2010, J Am Chem Soc, 132, p. 12690, Copyright 2010, American Chemical Society. Adapted with
permission [23].
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abilities to efficiently and specifically entrap cargo molecules.
The unique features of MSNs for high surface areas
(900e1500 m2/g), tunable pore size, large accessible pore vol-
umes (0.5e1.5 cm3/g), less toxicity, and biocompatibility make
them attractive vehicles for drug delivery. Since 2001, Maria
Vallet-Regı´’s research group proposed MSNs as drug delivery
systems for the first time [6]. A series of MSN-based stimuli-
responsive systems have been reported [7,8]. The drug release
is subsequently to be triggered by some external stimuli.
These external stimuli include: (1) physical signals such as
temperature [9,10], electric field [11], magnetic field [12], and
photo [13e15]; and (2) chemical signals such as ionic strength
[16], redox potential [17e19], and enzymatic activities [20,21].
However, in the past years, design of novel bio-responsive
nanocarriers that release drugs in response to an intracel-
lular signal, in particular acidic pH and redox potential, has
received great interest.
In this review, we critically discuss the recent de-
velopments related to the use of MSNs for drug delivery,
with special focus on cell environmentally responsive
mechanisms and highlight the use of pH-responsive, gluta-
thione (GSH)-responsive, adenosine-50-triphosphate (ATP)-responsive, glucose-responsive, and H2O2-responsive mech-
anisms in drug delivery. We also give our view on some of the
open challenges that need to be addressed in order to bring
the highly promising MSNs to practical use as drug delivery
vehicles.2. pH-responsive CDDSs
Among vigorous stimuli-responsive CDDSs, biological pH-
responsive drug delivery systems received the most
investigation since the human body exhibits variations in
pH along the gastrointestinal tract from the stomach
(pH ¼ 1.0e3.0), to the small intestine (pH ¼ 6.5e7.0), then to
the colon (pH ¼ 7.0e8.0) [22]. In addition, cancer cells have a
more acidic environment compared with normal cells.
Furthermore, tumor and inflammatory tissues are more
acidic than normal tissues and blood. Consequently, the
pH-responsive nano-DDSs based on MSNs have been
designed to achieve a site-selective controlled release.
There are three main methods to design pH-responsive
drug delivery. The caps such as polyamine and DNA were
linked on the surface of MSNs through electrostatic
Fig. 2 e Schematic illustration of pH-responsive nanogated ensemble based on gold-capped mesoporous silica through
acid-labile acetal linker. Note. From “pH-responsive nanogated ensemble based on gold-capped mesoporous silica through
an acid-labile acetal linker,” by R. Liu, Y. Zhang, X. Zhao, et al. 2010, J Am Chem Soc, 132, p. 1500. Copyright 2010, American
Chemical Society. Adapted with permission [26].
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condition. By contrast, the caps including supramolecular
stoppers and inorganic nanoparticles were anchored on the
surface of the MSNs by acid-labile bonds such as in acetals.
The third gating mechanism involves the reversible reac-
tion between polyalcohols and boronic acids to form bor-
onate esters. While at pH 2.0e4.0, the hydrolysis of the
boroester bond took place and thus resulted in a rapid
release of the entrapped drug.
Zink and coworkers developed several pH-responsive
mesoporous silica CDDSs utilizing the pH-dependent pseu-
dorotaxanes, rotaxanes, or other analogues [23e25]. In these
systems, the aromatic amines/ammonium stalks were
immobilized on the surface of the MSNs, and macrocyclic
movable gates were introduced to encircle the stalks for
controlling the flow of the drug models loaded in the pore
channels. For instance, the efficient macrocyclic movable gate
b-cyclodextrin (b-CD) was developed by Zink and coworkers
[23]. The nanovalve formation and cap release mechanism is
given in Fig. 1. The b-CD rings encircle aromatic amine stalks
as a result of noncovalent bonding interactions under neutral
pH conditions, and effectively block the nanopore openings,
and trap the included drug molecules. Decreasing the pH
under mildly acidic conditions leads to the protonation of the
aromatic amines and dissociation of b-CD caps, following drug
models diffusion from the nanopores.
Feng’s group has reported another pH-responsive nano-
gated ensemble by capping the gold nanoparticle onto themesoporous silica through an acid-labile acetal linker. As
shown in Fig. 2, at neutral pH, the linker remains intact and
pores are blocked with gold nanoparticles to strongly inhibit
the molecular diffusion from the pores. At acidic pHs, the
hydrolysis of the acetal group will remove the gold cap and
allow escape of the entrapped molecules in a pH-dependent
controlled release.
Amagnetic, reversible pH-responsive nanogated ensemble
based on Fe3O4 nanoparticle-cappedmesoporous silica, which
was capped onto the outlet of the mesoporous silica via an
acid-labile boronate ester linker was reported by Shi and
coworker. As shown in Fig. 3 [27], at neutral pH, the linker
remains intact and the entry of the pores on the MSNs are
blocked with Fe3O4 nanoparticles to strongly inhibit the mo-
lecular diffusion from the pores. At acidic pHs (pH < 4), the
Fe3O4 cap is removed due to the hydrolysis of the boronate
ester, allowing the release of the entrapped molecules.
Moreover, owing to the inherent reversibility of the boronate
ester reaction, a sustained, pulsatile release controlled by pH
value is realized easily.
Climent et al [28] modified MSNs with amino groups to
create a positively charged surface that interacts with nega-
tively charged DNAmolecules. Thus, the interaction of single-
stranded DNA molecules with the surface attached positively
charged amino groups resulted in an effective capping of the
pores. The nanoparticle cargo can be released when comple-
mentary DNA strand binds and displaces the adsorbed oligos
on the surface of nanoparticles (Fig. 4).
Fig. 3 e Schematic of (A) synthesis of the pH-responsive delivery system based on MSNs capped with Fe3O4 nanoparticles
and (B) reversible release system based upon pH. MSN[mesoporous silica nanoparticle. Note. From “Magnetic, reversible
pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica”, by Q. Gan, X. Lu, Y. Yuan,
et al., 2011, Biomaterials, 32, p. 1932. Copyright 2011, Elsevier Science. Adapted with permission [27].
Fig. 4 e Schematic representation of a valve system based on MSNs functionalized with amino groups and capped with a
single-stranded oligonucleotide (O1). Release of the trapped dye molecules is accomplished upon the addition of the
complementary oligonucleotide (O2). The sequence of the oligonucleotides O1 and O2 is shown. MSN[mesoporous silica
nanoparticle. Note. From “Controlled delivery using oligonucleotide-capped mesoporous silica nanoparticles”, by E.
Climent, R. Martinez-Manez, F. Sancenon, et al., 2010, Angew Chem Int Ed Engl, 49, p. 7281. Copyright 2010,Wiley. Reprinted
with permission [28].
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The development of glutathione-responsive nanovehicles for
targeted intracellular drug and gene delivery is very efficient.
Several intracellular compartments such as cytosol, mito-
chondria, and cell nucleus contain a high concentration of
GSH tripeptides (about 2e10 mM), which is 100e1000 times
higher than that in the extracellular fluids and circulation
(about 2e20 mM) [29]. Therefore, glutathione has been recog-
nized as an ideal and ubiquitous internal stimulus for rapid
destabilization of nano-carriers inside cells to accomplish
efficient intracellular drug release [30]. To establish GSH-
responsive drug delivery system, disulfide bonds were abso-
lutely necessary. The gatekeeper inorganic nanoparticles such
as CdS, Au, Fe3O4, and the organic part as the polyelectrolyte
are chemically attached to MSN through a disulfide linker,
which is chemically labile and could be cleaved with various
disulfide reducing agents, such as dithiothreitol (DTT) and
mercaptoethanol (ME).Fig. 5 e Schematic representation of the CdS nanoparticle-capp
controlled-release mechanism of the system is based on chemi
and the MSN hosts. MSN [ mesoporous silica nanoparticle. No
system with chemically removable CdS nanoparticle caps for s
and drug molecules”, by C.Y. Lai, B.G. Trewyn, D.M. Jeftinija, et
American Chemical Society. Adapted with permission [17].Lin and coworkers have creatively developed a series of
redox-responsive mesoporous silica CDDSs, in which CdS
nanoparticles [17], Fe3O4 nanoparticles [18], and poly(amido
amine) dendrimers [31] were used as the gatekeepers to cap
the pores, and various disulfide reducing agents as release
triggers. As an example of CdS nanoparticle-capped meso-
porous silica nanopheres (MNSs) redox-responsive CDDS
(Fig. 5), 2-(propyldisulfanyl) ethylamine groups on the surface
of the open mesopores covalently capture the water-soluble
mercaptoacetic acid derivatized CdS nanocrystals, resulting
in disulfide linkages. The linkages are chemically labile in
nature and can be cleaved with various disulfide-reducing
agents, such as DTT and ME. Hence, the release of the CdS
nanoparticle caps from the drug-loaded MSNs can be regu-
lated by introducing various amounts of release triggers.
Feng and coworkers reported redox-responsive nanogated
MSNs by grafting poly(N-acryloxysuccinimide) (PNAS) to the
pore entrance of MSN particles followed by cross-linking with
cystamine (Fig. 6) [32]. The release studies demonstrated that
the release rate of rhodamine B was dependent on theed MSN-based drug/neurotransmitter delivery system. The
cal reduction of the disulfide linkage between the CdS caps
te. From “A mesoporous silica nanosphere-based carrier
timuli-responsive controlled release of neurotransmitters
al., 2003, J Am Chem Soc, 125, p. 4451. Copyright 2003,
Fig. 6 e Schematic representation of redox-responsive nanovalves based on polymeric network-capped MSNs (top) and
multi-responsive nanovalves based on supramolecular polymeric network-capped MSNs (bottom). In the first system,
PNAS-coated MSNs are first loaded with dyes, then their valves closed with the cross-linking of the polymer chains by the
addition of a disulfide-based cystamine. The polymeric network formed can then be reopened by cleaving the disulfide bond
of cystamine in the presence of DTT, leading to the cargo release. In the second system, poly-CD-MS filled with cargos are
blocked by adding diazo linker to cross-link the b-CD-bearing polymer chains. Release of cargo molecules calcein is
achieved by the cleavage of the polymeric network using UV irradiation, competitive binding, or the addition of disulfide
reducing agent DTT. DTT [ dithiothreitol; MSN [ mesoporous silica nanoparticles; PNAS [ poly(N-acryloxysuccinimide);
UV [ ultraviolet; CD-MS = cyclodextrin-mesoprous silica. Note. From “Tunable redox-responsive hybrid nanogated
ensembles”, by R. Liu, X. Zhao, T. Wu, et al., 2008, J Am Chem Soc, 130, p. 14418. Copyright 2008, American Chemical Society.
Reprinted with permission [32].
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ensembles (with 1,6-hexadiamine) showed no induced
release with the addition of DTT.4. ATP-responsive CDDSs
Although many of the internalized carriers will release the
drug within the lysosome, some of the drug delivery vehicles
may escape from the lysosome before drug release. Hence,
there is also a need for a stimulus in the cytosol to trigger drugrelease. ATP is amultifunctional nucleotide, which plays a vital
role in many biological processes, including muscle contrac-
tion, cells functioning, synthesis and degradation of important
cellular compounds, and membrane transport. Owing to ATP
being predominantly present in the cytosol [33] and assuming
the concentration of ATP inside cells is high enough to release
the drug (concentration range of 1e10mM) [34], it is considered
as an important stimulus for drug release in the cytosol. Thus,
the development of ATP-responsive controlled-release system
for bioorganism application is very significant. Our group has
first reported a novel bio-responsive controlled-release system
Fig. 7 e Schematic illustration of aptameretarget-
interaction-responsive controlled-release system.
AuNPseaptamer is capped on the MSA surface because of
the binding reaction of the ATP aptamer to the adenosine
molecule. The delivery of the entrapped guest (fluorescein)
is selectively triggered by an effective displacement
reaction in the presence of the target molecule (ATP).
ATP [ adenosine-50-triphosphate. Note. From
“Bioresponsive controlled release using mesoporous silica
nanoparticles capped with aptamer-based molecular
gate”, by C.L. Zhu, C.H. Lu, X.Y. Song, et al., 2011, J Am Chem
Soc, 133, p. 1278. Copyright 2011, American Chemical Society.
Reprinted with permission [35].
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particles (Fig. 7), which is stimuli-responsive to the apta-
mereATP interactions [35]. In this work, MCM-41 tailed with
amino group was selected as support, and further functional-
ized with adenosine-50-carboxylic acid (adenosineeCOOH)da
derivative of the ATP target to give MSA. Gold nanoparticles
were functionalized with ATP aptamer through AueS bond toFig. 8 e Aptamer-based switchable nanovalves. (A) symbolically
the hairpin of the ATP-binding aptamer in the presence or abse
MSNs. ATP [ adenosine-50-triphosphate; MSN [ mesoporous
nanovalves for stimuli-responsive drug delivery”, by V.C. O¨zalp
Wiley. Reprinted with permission [36].form AuNPseaptamer. As the binding reaction of ATP aptamer
with adenosine resulted from the recognition of ATP
aptamer to the adenine and ribose moieties, upon mixing
AuNPseaptamer with MSA, AuNPs would block the pores of
MSA. The release of cargo molecules’ fluorescein isothiocya-
nate (FITC) dye from these AuNPs-gatedMSNswas triggered by
the addition of ATPmolecules, which resulted in a competitive
displacement reaction to the adenosineeaptamer interaction
to uncap the pores of MSNs. The selectivity of this delivery
process was tested with the ATP analogs CTP, GTP, and UTP,
but a characteristic release of the dye similar to the release of
ATP was not observed.
Another ATP-based controlled-release system was pub-
lished by O¨zalp and Scha¨fer’s group. They directly used ATP-
aptamer gated MCM-41 nanoparticles for the selective and
reversible detection of ATP by release of fluorescein [36]. The
aptamers were immobilized on the surface of the MSNs con-
taining the dye in the pores. The release of the dyewas induced
by the denaturation of the double-strand region of the aptamer
close to the pore gates by specific complexation of ATP (Fig. 8).
Theporesof themesoporousmaterial haveadiameter of 2.6nm
and a double DNA helix has a thickness of 2 nm. Therefore, it is
supposed that the similar diameter of the hairpin-type aptam-
ers on the material’s surface blocks the pores of the nano-
particles.Accordingly, opening canbeachievedbydenaturation
with ATP and the formation of a single-stranded neck region,
which permits the dye to diffuse out of the pores.
Jiang et al developed an efficient, smart gating system based
on ATP molecules-ATP aptamer and its complementary DNA,
which exhibited extremely high ON-OFF ratios and nearly per-
fect electric seals in its closed state [37]. The open-to-closed
process is achieved by self-assembling super-sandwichshows changes in the secondary and tertiary structure of
nce of ATP. (B) ATP-triggered release of fluorescein from
silica nanoparticle. Note. From “Aptamer-based switchable
and T. Scha¨fer, 2011, Chem Eur J, 17, p. 9893. Copyright 2011,
Fig. 9 e Schematic illustration of aptamer-based ATP responsive MSN system. ATP [ adenosine-50-triphosphate;
MSN [ mesoporous silica nanoparticle. Note. From “ATP-responsive controlled release system using aptamer-
functionalized mesoporous silica nanoparticles”, 2012, by X.X. He, X.Y. Zhao, D.G. He, et al., Langmuir, 28, p. 12909.
Copyright 2012, American Chemical Society. Reprinted with permission [38].
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DNA into solid-state nanochannels, while the closed-to-open
process is realized by the disassembly of ATP-ATP aptamer
binding. He and coworkers reported another example that they
developed an ATP-responsive controlled-release system using
aptamer-functionalized MSNs [38]. In this system, as shown in
Fig. 9, the ATP aptamer is first hybridized with arm single-
stranded DNA1 (arm ssDNA1) and arm single-stranded DNA2
(arm ssDNA2) to form the sandwich-type DNA structure and
then grafted onto the MSN surface through click chemistry
approach, resulting in blockage of pores and inhibition of guest
molecules release. In the presence of ATP, the ATP aptamer
combinedwithATPandgot away fromthepore, leaving thearm
ssDNA1 and ssDNA2 on the surface of MSN. The guest mole-
cules can be released because single-stranded DNA is flexible.
The release of the guestmolecules from this systemthencanbe
triggered by the addition of ATP.5. Glucose-responsive CDDSs
Glucose-responsive materials have attracted great intention in
recent years because of their potential application in drug de-
livery [39]. Saccharides are also a suitable target because of
their unique interaction with boronic acids. According to this
principle, Lin and coworkers have described on the synthesis of
a glucose-responsive MSN-based double delivery system for
both insulin and cAMP with precise control over the sequence
of release [40]. As depicted in Fig. 10, gluconic acid-modified
insulin (G-Ins) proteins are immobilized on the exterior sur-
face of MSN and also serve as caps to encapsulate cAMP mol-
ecules inside the mesopores of MSN. The release of both G-Insand cAMP from MSN can be triggered by the introduction of
saccharides, such as glucose. Moreover, they have demon-
strated that the uncapped MSN can be efficiently endocytosed
by live mammalian cells, leading to the effective intracellular
release of the cell-membrane-impermeable cAMP. This
glucose-responsive controlled-insulin-release system (GRCIRS)
was expected to be a new and highly promising therapy
approach to replace the frequent insulin injections to cure
diabetes, one urgent medical challenge worldwide.
Another glucose-responsive controlled-release system
based on the competitive combination between glucose oxi-
dase (GOD), glucosamine, and glucose has been reported by
Zhu’s group [41], which exhibits perfect controlled-release
properties and high selectivity for glucose over other mono-
saccharides. The design strategy relies on the unique
interaction between an inhibitor, an enzyme and a substrate
(Fig. 11). The external surface of MCM-41 was first function-
alized with D-(þ)-glucosamine, an effective inhibitor of GOD.
Rhodamine B (RB) was utilized as a model drug for convenient
detection. GOD was selected as the capping agent because it
can combine with D-(þ)-glucosamine anchored outside the
pores to form an enzyme inhibitor (EI) complex, which acts as
a “bio-gate,” resulting in the closing of the mesopores. The
opening event will occur by a highly effective competitive
combination of glucose (substrate) and GOD, which forms the
enzymeesubstrate (ES) complex, then uncaps the pores and
releases the entrapped guest molecules.
More recently, a glucose- and pH-responsive controlled
release of cargo from protein-gated carbohydrate-functional-
ized mesoporous silica nanocontainers was reported by Du’s
group [42]. MSNswere functionalizedwithmannose ligands at
optimized surface densities. Tight concanavalin A (Con A)
Fig. 10 e (A) Schematic representation of the glucose-responsive MSN-based delivery system for controlled release of
bioactive G-Ins and cAMP. Transmission electron micrographs of (B) boronic acid-functionalized MSN and (C) FITC-G-Ins-
capped MSN. FITC [ fluorescein isothiocyanate; G-Ins [ gluconic acid-modified insulin. Note. From “Mesoporous silica
nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP”, by Y.
Zhao, B.G. Trewyn, I.I. Slowing, et al., 2009, J Am Chem Soc, 131, p. 8398. Copyright 2009, American Chemical Society. Reprinted
with permission [40].
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hydrateeprotein interactions to encapsulate the cargo within
the pores, and the cargo was released by competitive binding
of glucose when the normal blood-glucose concentration be-
comes elevated, which would have potential applications for
diabetes therapy. In addition, the drug could also be released
by introducing an acidic environment, such as is found in
tumor cells and inflammatory tissues.6. H2O2-responsive CDDS
A biocompatible delivery platform by using H2O2-responsive
controlled-release system to realize target delivery of AD
therapeutic metal chelator was reported by Qu’s group [43]. Asshown in Fig. 12, the advantage of this novel strategy is that
metal chelator can only be released by the increased levels of
H2O2; thus, it would not interfere with the healthy metal ho-
meostasis and can overcome strong side effects of metal
chelator after long-term use. By taking advantage of the good
biocompatibility, cellular uptake properties, and efficient
intracellular release of metal chelators, the delivery system is
promising for future in vivo controlled-release biomedical
applications.7. Conclusion
In this review, we have highlighted some exciting research
progress on mesoporous silica-based materials as cell
Fig. 11 e Schematic illustration of enzyme-inhibition-mechanism-triggered release of guest molecules from the pores of
functionalized mesoporous silica materials. Note. From “Glucose-responsive controlled release system using glucose
oxidase-gated mesoporous silica nanocontainers”, by M.J. Chen, C.S. Huang, C.S. He, et al. Chem Commun, 48, p. 9522.
Copyright 2012, The Royal Society of Chemistry. Reprinted with permission [41].
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systems. These smart nano-CDDSs can be delivered into tar-
geted organs or cells and release drugs in some controlled
manner by the virtue of various internal triggers, such as pH,Fig. 12 e Schematic representation of H2O2-fueled release
of guest molecules CQ from the pores of MSN capped with
IgG. CQ can chelate Cu2 D to disassemble Ab plaques and
inhibit H2O2 production. CQ [ clioquinol;
MSN [ mesoporous silica nanoparticles. Note. From
“Mesoporous silica nanoparticle-based H2O2 responsive
controlled-release system used for Alzheimer’s disease
treatment”, by J. Geng, M. Li, L. Wu, et al., 2012, Adv
Healthcare Mater, 1, p. 332. Copyright 2012, Wiley.
Reprinted with permission [43].ATP, GSH, glucose, and H2O2, which is encouraging and shows
great promise in biomedical applications. However, there are
still a great many challenges, especially the in vivo-applicable
stimuli-responsive mechanisms, which need to be under-
stood and investigated more comprehensively and thor-
oughly. In addition, the challenging goal to these nanocarriers
of releasing the guest molecules in vivo in a site- and time-
specific manner still has to be demonstrated. Some bio-
molecules such as peptide sequences, enzymes, DNA or
collagen as “bio-gates” are still in their infancy.
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